Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Ferrero

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
The International Journal of Biological Markers|February 6, 2004
Prognostic value of S-phase fraction in 920 breast cancer patients: focus on T1N0 statusR Largillier, M Namer, A Ramaioli, et al.
Oncology|September 6, 2007
Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcomeA Courdi, R Largillier, J-M Ferrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicityS Beauclair, P Formento, J L Fischel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 10, 2009
[CyberKnife and neoadjuvant chemotherapy for breast tumors: preliminary results]P-Y Bondiau, M Lallement, P Bahadoran, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 29, 2014
Intraoperative radiological margin assessment in breast-conserving surgeryT Ihrai, D Quaranta, Y Fouche, et al.
Oncology|March 1, 2014
Prognostic factors in 401 elderly women with metastatic breast cancerP Follana, J Barrière, E Chamorey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 16, 2010
[Second conservative radiosurgical treatment for ipsilateral breast cancer recurrence]J Castelli, A Figl, I Raoust, et al.
Bulletin Du Cancer|January 1, 1997
[A comparative study of 4 sequential first-line chemotherapy protocols in locally advanced breast cancer]J M Ferrero, M Namer, J F Dufour, et al.
Journal of Cancer Research and Clinical Oncology|June 27, 2007
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancerO Guérin, P Formento, C Lo Nigro, et al.
European Journal of Cancer Care|November 11, 2011
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudesI Pellegrini, M Rapti, J-M Extra, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
The International Journal of Biological Markers|February 6, 2004
Prognostic value of S-phase fraction in 920 breast cancer patients: focus on T1N0 statusR Largillier, M Namer, A Ramaioli, et al.
Oncology|September 6, 2007
Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcomeA Courdi, R Largillier, J-M Ferrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicityS Beauclair, P Formento, J L Fischel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 10, 2009
[CyberKnife and neoadjuvant chemotherapy for breast tumors: preliminary results]P-Y Bondiau, M Lallement, P Bahadoran, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 29, 2014
Intraoperative radiological margin assessment in breast-conserving surgeryT Ihrai, D Quaranta, Y Fouche, et al.
Oncology|March 1, 2014
Prognostic factors in 401 elderly women with metastatic breast cancerP Follana, J Barrière, E Chamorey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 16, 2010
[Second conservative radiosurgical treatment for ipsilateral breast cancer recurrence]J Castelli, A Figl, I Raoust, et al.
Bulletin Du Cancer|January 1, 1997
[A comparative study of 4 sequential first-line chemotherapy protocols in locally advanced breast cancer]J M Ferrero, M Namer, J F Dufour, et al.
Journal of Cancer Research and Clinical Oncology|June 27, 2007
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancerO Guérin, P Formento, C Lo Nigro, et al.
European Journal of Cancer Care|November 11, 2011
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudesI Pellegrini, M Rapti, J-M Extra, et al.
Pageof 8